Dillico developed the All-ScaleFlow manufacturing platform, an end-to-end automated continuous production equipment for m/sa/gRNA-LNP therapeutics with related digital tools and services. This solution enables efficient in-silico process development for any mRNA therapeutics, leveraging a Performance Modeling Platform. The continuous production is scale-up free and can process batches ranging from pre-clinical or individualized medicine scale to large commercial scale. The All-ScaleFlow is a powerful tool to accelerate the advancement of m/sa/gRNA assets through the pipeline.
Advanced Biomanufacturing and Ecosystem Enablers
Scale-up and manufacturing of complex therapiesMicro-factories for decentralised biomanufacturingTechnology transfer optimisation